Info

M&A Science

M&A Science is a podcast exploring the intricate world of mergers and acquisitions with industry leaders and practitioners. With an unlimited access to our deal network, these interviews examine M&A trends, culture, and best practices. This podcast is sponsored by DealRoom, an M&A lifecycle management platform.
RSS Feed Subscribe in Apple Podcasts
M&A Science
2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April


2018
July
June
May
February


2017
December
September
March
February


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Sep 8, 2022

Christina Ungaro, VP, Head of Corporate Development at Wind River

Corporate development is more than just doing M&A. Sometimes, acquiring a company isn't the best way to achieve the organization's growth strategy. There are a variety of approaches to accelerating a business that require extra analysis and planning.

In this episode of the M&A Science Podcast, Christina Ungaro, VP, Head of Corporate Development at Wind River, talks about growing beyond M&A. 

Liked today's episode? Unlock over 50 courses taught by top-tier M&A practitioners by joining the M&A Science Academy. Use code “podcast” on the sign-up page for a 20% discount, available on either monthly or annual plans. https://www.mascience.com/academy

Want to learn about upcoming interviews, events, and industry trends? Sign up for our weekly newsletter. https://www.mascience.com/newsletter-signup 

If you’re a head of corporate development and looking to build up a world-class M&A team, reach out to me at kison@mascience.com.

This episode is sponsored by FirmRoom, the fastest virtual data room used to get deals done. Leave the pay-per-page world behind by going to https://firmroom.com/

0 Comments
Adding comments is not available at this time.